Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 3/20 | 0.31 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7238417 | 0.95 | BTK (0.40) | BTKKMT2AEPHX1L3MBTL1CTSK | |
| SCHEMBL7238413 | 0.94 | BTK (0.35) | BTKKMT2AEPHX1L3MBTL1CTSK | |
| SCHEMBL7239017 | 0.93 | BTK (0.44) | BTKKMT2AEPHX1L3MBTL1CTSK | |
| SCHEMBL7231875 | 0.88 | BTK (0.40) | BTKKMT2AEPHX1L3MBTL1CTSK | |
| SCHEMBL7233863 | 0.87 | BTK (0.32) | BTKEPHX1CTSKKDM1ANFKB1 | |
| SCHEMBL7230862 | 0.86 | BTK (0.37) | BTKKMT2AEPHX1CTSKCTSS | |
| SCHEMBL7230514 | 0.86 | BTK (0.37) | BTKKMT2AEPHX1CTSKCTSS | |
| SCHEMBL7230501 | 0.83 | EPHX1 (0.36) | BTKKMT2AEPHX1MAOB | |
| SCHEMBL7231707 | 0.80 | — | — | |
| SCHEMBL7235646 | 0.80 | BTK (0.44) | BTKKMT2AEPHX1L3MBTL1CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6518305-B1 | For inhibiting neuraminidases from disease- causing microorganisms, especially, influenza neuraminidase | ABBOTT LABORATORIES | 2003-02-11 | — | — | US | claimed |
| US-6518305-B1 | For inhibiting neuraminidases from disease- causing microorganisms, especially, influenza neuraminidase | ABBOTT LABORATORIES | 2003-02-11 | — | — | US | disclosed |